558 Citations (Scopus)

Abstract

Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.

Original languageEnglish (US)
Pages (from-to)608-624
Number of pages17
JournalEndocrine reviews
Volume19
Issue number5
DOIs
StatePublished - Oct 22 1998

Fingerprint

Insulin
Fats
Hormones
Proteins
Steroid Receptors
Proteasome Endopeptidase Complex
Lysosomes
Type 2 Diabetes Mellitus
Signal Transduction
Obesity
Enzymes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Insulin degradation : Progress and potential. / Duckworth, William C.; Bennett, Robert G; Hamel, Frederick G.

In: Endocrine reviews, Vol. 19, No. 5, 22.10.1998, p. 608-624.

Research output: Contribution to journalReview article

Duckworth, William C. ; Bennett, Robert G ; Hamel, Frederick G. / Insulin degradation : Progress and potential. In: Endocrine reviews. 1998 ; Vol. 19, No. 5. pp. 608-624.
@article{d04587949e214945961f63d1930e178d,
title = "Insulin degradation: Progress and potential",
abstract = "Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.",
author = "Duckworth, {William C.} and Bennett, {Robert G} and Hamel, {Frederick G}",
year = "1998",
month = "10",
day = "22",
doi = "10.1210/er.19.5.608",
language = "English (US)",
volume = "19",
pages = "608--624",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Insulin degradation

T2 - Progress and potential

AU - Duckworth, William C.

AU - Bennett, Robert G

AU - Hamel, Frederick G

PY - 1998/10/22

Y1 - 1998/10/22

N2 - Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.

AB - Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.

UR - http://www.scopus.com/inward/record.url?scp=0031690490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031690490&partnerID=8YFLogxK

U2 - 10.1210/er.19.5.608

DO - 10.1210/er.19.5.608

M3 - Review article

C2 - 9793760

AN - SCOPUS:0031690490

VL - 19

SP - 608

EP - 624

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 5

ER -